Interferon Beta Drugs Slow the Progression of Relapsing Multiple Sclerosis and Reduce the Frequency of Clinical Symptoms
Interferon beta drugs are a part of the normal standard therapy for patients suffering from multiple sclerosis. Interferon beta-1b slows the progression of relapsing multiple sclerosis and reduces the frequency of clinical symptoms. However, as a consequence of multiple sclerosis and especially when an immune deficiency disorder is involved, the use of these drugs for treating multiple sclerosis victims can sometimes prove to be inappropriate. Furthermore, it has also been used for the therapy of hepatitis C in Japan previously but is currently not approved for the therapeutic treatment of HCV in many countries. Multiple sclerosis patients usually respond very well to interferon beta drugs . The drugs are administered in combination with other medications and therapies such as phototherapy, cortisone, and biologic therapy which can also have favorable results in some patients. Phototherapy uses light-activated substances such as water, vegetables, and algae to suppress MS-inflammat